AIM: To decipher the molecular interactions between c-Met and its type I inhibitors and to facilitate the design of novel c-Met inhibitors. METHODS: Based on the prototype model inhibitor 1, four ligands with subtle differences in the fused aromatic rings were synthesized. Quantum chemistry was employed to calculate the binding free energy for each ligand. Symmetry-adapted perturbation theory (SAPT) was used to decompose the binding energy into several fundamental forces to elucidate the determinant factors. RESULTS: Binding free energies calculated from quantum chemistry were correlated well with experimental data. SAPT calculations showed that the predominant driving force for binding was derived from a sandwich π-π interaction with Tyr-1230. Arg-1208 was the differentiating factor, interacting with the 6-position of the fused aromatic ring system through the backbone carbonyl with a force pattern similar to hydrogen bonding. Therefore, a hydrogen atom must be attached at the 6-position, and changing the carbon atom to nitrogen caused unfavorable electrostatic interactions. CONCLUSION: The theoretical studies have elucidated the determinant factors involved in the binding of type I inhibitors to c-Met.
AIM: To decipher the molecular interactions between c-Met and its type I inhibitors and to facilitate the design of novel c-Met inhibitors. METHODS: Based on the prototype model inhibitor 1, four ligands with subtle differences in the fused aromatic rings were synthesized. Quantum chemistry was employed to calculate the binding free energy for each ligand. Symmetry-adapted perturbation theory (SAPT) was used to decompose the binding energy into several fundamental forces to elucidate the determinant factors. RESULTS: Binding free energies calculated from quantum chemistry were correlated well with experimental data. SAPT calculations showed that the predominant driving force for binding was derived from a sandwich π-π interaction with Tyr-1230. Arg-1208 was the differentiating factor, interacting with the 6-position of the fused aromatic ring system through the backbone carbonyl with a force pattern similar to hydrogen bonding. Therefore, a hydrogen atom must be attached at the 6-position, and changing the carbon atom to nitrogen caused unfavorable electrostatic interactions. CONCLUSION: The theoretical studies have elucidated the determinant factors involved in the binding of type I inhibitors to c-Met.
Authors: Rosendo Valero; Ramon Costa; Ibério de P R Moreira; Donald G Truhlar; Francesc Illas Journal: J Chem Phys Date: 2008-03-21 Impact factor: 3.488
Authors: Claudio A Morgado; Jonathan P McNamara; Ian H Hillier; Neil A Burton; Mark A Vincent Journal: J Chem Theory Comput Date: 2007-09 Impact factor: 6.006
Authors: Brian K Albrecht; Jean-Christophe Harmange; David Bauer; Loren Berry; Christiane Bode; Alessandro A Boezio; April Chen; Deborah Choquette; Isabelle Dussault; Cary Fridrich; Satoko Hirai; Doug Hoffman; Jay F Larrow; Paula Kaplan-Lefko; Jasmine Lin; Julia Lohman; Alexander M Long; Jodi Moriguchi; Anne O'Connor; Michele H Potashman; Monica Reese; Karen Rex; Aaron Siegmund; Kavita Shah; Roman Shimanovich; Stephanie K Springer; Yohannes Teffera; Yajing Yang; Yihong Zhang; Steven F Bellon Journal: J Med Chem Date: 2008-04-22 Impact factor: 7.446
Authors: Uta Drebber; Stephan E Baldus; Britt Nolden; Guido Grass; Elfriede Bollschweiler; Hans P Dienes; Arnulf H Hölscher; Stefan P Mönig Journal: Oncol Rep Date: 2008-06 Impact factor: 3.906